Major push by Gavi, the Vaccine Alliance and lower-income countries to extend access to the HPV vaccine has reached its target ahead of schedule.

Brazil commits US$ 72 million to Gavi’s 2026–2030 strategic period, reinforcing its role as a key stakeholder in global health and vaccine manufacturing.

Hungary makes first-ever pledge to Gavi, the Vaccine Alliance with EUR 1 million commitment, joining a growing group of new donors to Gavi’s 2026–2030 funding cycle.

More than a decade after the first HPV vaccination programmes rolled out, data from multiple countries reveals a dramatic fall in cervical cancers and precancers, confirming that HPV vaccines are highly effective and extremely safe.

In 2009, almost a fifth of pregnant women at Nepal’s main maternity hospital were infected with rubella, a virus that causes miscarriages and birth defects. The road to safety has demanded grit and consistency, health workers say. 

As a new branch of H3N2 influenza gains ground, we explore what it means for this season’s flu vaccine.